TDAC Q2 2023 Earnings Report — Translational Development Acquisition Corp. Revenue & Financial Results | Market Cap Arena

Translational Development Acquisition Corp.TDAC

Q2 2023 Earnings

Reported June 30, 2023

Quarter Comparison

Revenue

Operating Income

EPS (Diluted)

Free Cash Flow

Metric	Q2 2023	Q1 2023	Q2 2022	QoQ Change	YoY Change
Revenue	$0	$0	$0	—	—
Op. Income	-$602	-$602	-$1.7K	0.0%	64.5%
EPS (Diluted)	$-0.00	$-0.00	$-0.00	0.0%	80.0%
Free Cash Flow	-$102	-$102	$0	0.0%	—

Income Statement

Item	Amount
REVENUE	$0
Cost of Revenue	$0
GROSS PROFIT	$0
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$602
SG&A Expenses	$602
Other Expenses	$0
Operating Expenses	$602
Cost & Expenses	$602
OPERATING INCOME	-$602
Interest Income	$0
Interest Expense	$0
Other Income/Expenses	$0
INCOME BEFORE TAX	-$602
Income Tax Expense	$0
Net Income from Continuing Ops	-$602
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	-$602
Net Income Deductions	$0
BOTTOM LINE NET INCOME	-$602
D&A	$602
EBIT	-$602
EBITDA	$0
EPS	-$0
EPS Diluted	-$0

Cash Flow Statement

Item	Amount
Net Income	-$602
Depreciation & Amortization	$0
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$0
Change in Working Capital	$500
OPERATING CASH FLOW	-$102
Capital Expenditure	$0
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	$0
Net Debt Issuance	$0
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$0
NET CASH FROM FINANCING	$0
FREE CASH FLOW	-$102
Net Change in Cash	$2.2K